FDA Clearance Tracker · P990026-S021
GLUCOWATCH G2 BIOGRAPHER
Last checked: Nov 20, 2026Latest source record: Feb 25, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Feb 25, 2004
Approved
Time to decision
147 days
Received Oct 1, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P990026-S021
- Device name
- GLUCOWATCH G2 BIOGRAPHER
- Applicant
- Animas Corp.
- Applicant location
- West Chester, PA
- Received
- Oct 1, 2003
- Decided
- Feb 25, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990026
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AN EXPANSION OF THE LABELING TO INCLUDE A DESCRIPTION OF PRE-TREATMENT PRODUCTS AND A METHOD TO MINIMIZE THE AFFECTS OF SKIN IRRITATION WITHOUT AFFECTING THE ACCURACY OF G2 BIOGRAPHER GLUCOSE MEASUREMENTS.
Source documents
Other decisions for Animas Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- OneTouch Vibe Plus SystemPMA supplement
P130007-S016 · Decided Dec 16, 2016 · 193 days after receipt · Panel Track
Device type: Pump, infusion, insulin, to be used with invasive glucose sensor (OYC) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.